Diamond Biotechnology Co., Ltd (TPEX:6815)

Diamond Biotechnology Income Statement

Financials in millions TWD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Revenue	698.11	768.25	616.1	434.84	395.2	306.39
Revenue Growth (YoY)	-1.33%	24.70%	41.68%	10.03%	28.99%	14.17%
Cost of Revenue	413.99	437.54	326.5	250.53	207.32	177.96
Gross Profit	284.12	330.71	289.59	184.32	187.88	128.43
Selling, General & Admin	180.9	176.56	194.89	111.31	111.86	112.14
Research & Development	43.37	41.4	29.33	25.94	27.93	2.89
Operating Expenses	234.55	222.4	225.69	138.1	140	113.44
Operating Income	49.57	108.31	63.91	46.22	47.88	14.99
Interest Expense	-5.72	-7.44	-7.52	-3.74	-2.27	-2.48
Interest & Investment Income	2.46	1.89	0.7	0.43	0.04	0.05
Currency Exchange Gain (Loss)	0.22	0.33	0.08	-0.35	0.06	0.07
Other Non Operating Income (Expenses)	0.82	-2.68	1.17	-0.83	2.86	-0.06
EBT Excluding Unusual Items	47.34	100.4	58.33	41.73	48.57	12.57
Gain (Loss) on Sale of Investments	-	-	-	-	0.03	-
Gain (Loss) on Sale of Assets	1.15	-4.72	-	0.1	1.35	0.72
Other Unusual Items	-	-	-	-	2.11	0.21
Pretax Income	48.5	95.69	58.33	41.82	52.05	13.51
Income Tax Expense	13.32	22.49	11.59	8.44	10.13	2.46
Net Income	35.17	73.2	46.74	33.39	41.92	11.05
Net Income to Common	35.17	73.2	46.74	33.39	41.92	11.05
Net Income Growth	-45.33%	56.61%	39.98%	-20.35%	279.40%	-74.99%
Shares Outstanding (Basic)	40	38	37	36	36	35
Shares Outstanding (Diluted)	40	39	37	36	36	35
Shares Change (YoY)	7.30%	4.92%	1.02%	-0.00%	3.35%	17.19%
EPS (Basic)	0.89	1.90	1.27	0.92	1.15	0.31
EPS (Diluted)	0.89	1.90	1.27	0.92	1.15	0.31
EPS Growth	-49.05%	49.29%	39.10%	-20.60%	269.48%	-78.81%
Free Cash Flow	55.42	4.44	-155.72	84.57	-19.25	14.79
Free Cash Flow Per Share	1.40	0.12	-4.24	2.33	-0.53	0.42
Dividend Per Share	0.166	0.166	0.136	0.083	0.105	0.027
Dividend Growth	22.01%	22.01%	63.63%	-20.67%	283.21%	-96.76%
Gross Margin	40.70%	43.05%	47.01%	42.39%	47.54%	41.92%
Operating Margin	7.10%	14.10%	10.37%	10.63%	12.12%	4.89%
Profit Margin	5.04%	9.53%	7.59%	7.68%	10.61%	3.61%
Free Cash Flow Margin	7.94%	0.58%	-25.27%	19.45%	-4.87%	4.83%
EBITDA	72.17	131.52	91.49	73.94	79.64	43.16
EBITDA Margin	10.34%	17.12%	14.85%	17.00%	20.15%	14.09%
D&A For EBITDA	22.59	23.21	27.58	27.72	31.76	28.18
EBIT	49.57	108.31	63.91	46.22	47.88	14.99
EBIT Margin	7.10%	14.10%	10.37%	10.63%	12.12%	4.89%
Effective Tax Rate	27.47%	23.50%	19.88%	20.17%	19.46%	18.19%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.